AI201901 / Abdi Ibrahim Pharma - LARVOL DELTA

HILARIA: Efficacy and Safety Study of AI201901 in Allergic Rhinitis Patients (clinicaltrials.gov) - P3 | N=210 | Completed | Sponsor: Abdi Ibrahim Ilac San. ve Tic A.S. | Recruiting ➔ Completed | Trial completion date: Dec 2022 ➔ May 2023 | Trial primary completion date: Nov 2022 ➔ Mar 2023

Trial completion • Trial completion date • Trial primary completion date • Allergic Rhinitis • Immunology • Inflammation